Apyx Medical Corp expected to post a loss of 14 cents a share - Earnings Preview

Apyx Medical

14/03/2023 13:46

* Apyx Medical Corp  APYX.OQ   APYX.O  is expected to show a
fall
in quarterly revenue when it reports  results on March 16. 
    * The Clearwater Florida-based  company is expected to
report  a
23.1% decrease in revenue to $12.936 million from $16.82 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. The company's guidance on January 10
2023, for the period ended December 31, was for revenue between
$12.10 million and $12.50 million.
    * ​Refinitiv's mean analyst estimate for Apyx Medical Corp
is for
a loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Apyx
Medical Corp
is $7.5​, above​ its last closing price of $2.79. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.15       -0.14      -0.17     Missed  -17.2
 Jun. 30 2022  -0.19       -0.19      -0.16     Beat    14.7
 Mar. 31 2022  -0.14       -0.15      -0.17     Missed  -15.9​
 Dec. 31 2021  -0.10       -0.11      -0.06     Beat    45.5
 ​​Sep.        -0.15       -0.15      -0.12     Beat    20
 30 2021                                                
 Jun. 30 2021  -0.16       -0.15      -0.12     Beat    18.5​
 Mar. 31 2021  -0.14       -0.14      -0.14     Met     1.8
 Dec. 31 2020  -0.11       -0.11      -0.04     Beat    64.3
 This summary was machine generated March 14 at 13:46 GMT.  All
figures in US dollars  unless otherwise stated